CD8A and neoplasm: DAMPs act as adjuvants for antigen-presenting cells (e.g., DCs), facilitating their recruitment and maturation, the subsequent cross-presentation of antigenic peptides to CD8+ T cells, and the activation of a strong anti-tumor immune response [3,40,41].